Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment

被引:53
作者
Shea, Karen L. [1 ]
Gavin, Kathleen M. [1 ]
Melanson, Edward L. [1 ,2 ]
Gibbons, Ellie [1 ]
Stavros, Anne [1 ]
Wolfe, Pamela [3 ]
Kittelson, John M. [3 ]
Vondracek, Sheryl F. [4 ]
Schwartz, Robert S. [1 ]
Wierman, Margaret E. [2 ]
Kohrt, Wendy M. [1 ]
机构
[1] Univ Colorado, Dept Med, Div Geriatr Med, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Biostat & Informat, Aurora, CO 80045 USA
[4] Univ Colorado, Dept Clin Pharm, Aurora, CO 80045 USA
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2015年 / 22卷 / 10期
基金
美国国家卫生研究院;
关键词
Body composition; Bone mineral density; Fat mass; Fat-free mass; Menopause; Resistance exercise; EARLY POSTMENOPAUSAL WOMEN; ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; GNRH AGONIST THERAPY; REPLACEMENT THERAPY; MEDROXYPROGESTERONE ACETATE; CONJUGATED ESTROGENS; FAT DISTRIBUTION; HEART-DISEASE; SERUM LEPTIN;
D O I
10.1097/GME.0000000000000430
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Suppression of ovarian hormones in premenopausal women on gonadotropin-releasing hormone agonist (GnRH(AG)) therapy can cause fat mass (FM) gain and fat-free mass (FFM) loss. Whether this is specifically caused by a decline in serum estradiol (E-2) is unknown. This study aims to evaluate the effects of GnRH(AG) with placebo (PL) or E-2 add-back therapy on FM, FFM, and bone mineral density (BMD). Our exploratory aim was to evaluate the effects of resistance exercise training on body composition during the drug intervention. Methods: Seventy healthy premenopausal women underwent 5 months of GnRH(AG) therapy and were randomized to receive transdermal E-2 (GnRH(AG) + E-2, n = 35) or PL (GnRH(AG) + PL, n = 35) add-back therapy. As part of our exploratory aim to evaluate whether exercise can minimize the effects of hormone suppression, some women within each drug arm were randomized to undergo a resistance exercise program (GnRH(AG) + E-2 + Ex, n = 12; GnRH(AG) + PL + Ex, n = 12). Results: The groups did not differ in mean (SD) age (36 [8] and 35 [9] y) or mean (SD) body mass index (both 28 [6] kg/m(2)). FFM declined in response to GnRH(AG) + PL (mean, -0.6 kg; 95% CI, -1.0 to -0.3) but not in response to GnRH(AG) + E-2 (mean, 0.3 kg; 95% CI, -0.2 to 0.8) or GnRH(AG) + PL + Ex (mean, 0.1 kg; 95% CI, -0.6 to 0.7). Although FM did not change in either group, visceral fat area increased in response to GnRH(AG) + PL but not in response to GnRH(AG) + E-2. GnRH(AG) + PL induced a decrease in BMD at the lumbar spine and proximal femur that was prevented by E-2. Preliminary data suggest that exercise may have favorable effects on FM, FFM, and hip BMD. Conclusions: Suppression of ovarian E-2 results in loss of bone and FFM and expansion of abdominal adipose depots. Failure of hormone suppression to increase total FM conflicts with previous studies of the effects of GnRH(AG). Further research is necessary to understand the role of estrogen in energy balance regulation and fat distribution.
引用
收藏
页码:1045 / 1052
页数:8
相关论文
共 41 条
  • [1] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
    Anderson, GL
    Limacher, M
    Assaf, AR
    Bassford, T
    Beresford, SAA
    Black, H
    Bonds, D
    Brunner, R
    Brzyski, R
    Caan, B
    Chlebowski, R
    Curb, D
    Gass, M
    Hays, J
    Heiss, G
    Hendrix, S
    Howard, BV
    Hsia, J
    Hubbell, A
    Jackson, R
    Johnson, KC
    Judd, H
    Kotchen, JM
    Kuller, L
    LaCroix, AZ
    Lane, D
    Langer, RD
    Lasser, N
    Lewis, CE
    Manson, J
    Margolis, K
    Ockene, J
    O'Sullivan, MJ
    Phillips, L
    Prentice, RL
    Ritenbaugh, C
    Robbins, J
    Rossouw, JE
    Sarto, G
    Stefanick, ML
    Van Horn, L
    Wactawski-Wende, J
    Wallace, R
    Wassertheil-Smoller, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
  • [2] Changes in serum leptin levels during GnRH agonist therapy
    Douchi, T
    Kuwahata, T
    Yoshimitsu, N
    Iwamoto, I
    Yamasaki, H
    Nagata, Y
    [J]. ENDOCRINE JOURNAL, 2003, 50 (03) : 355 - 359
  • [3] Inverse relationship between the changes in trunk lean and fat mass during gonadotropin-releasing hormone agonist therapy
    Douchi, T
    Kuwahata, R
    Yamasaki, H
    Yamamoto, S
    Oki, T
    Nakae, M
    Nagata, Y
    [J]. MATURITAS, 2002, 42 (01) : 31 - 35
  • [4] Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women
    Dumesic, DA
    Abbott, DH
    Eisner, JR
    Herrmann, RR
    Reed, JE
    Welch, TJ
    Jensen, MD
    [J]. FERTILITY AND STERILITY, 1998, 70 (01) : 94 - 101
  • [5] Effect of postmenopausal hormone therapy on body weight and waist and hip girths
    Espeland, MA
    Stefanick, ML
    KritzSilverstein, D
    Fineberg, SE
    Waclawiw, MA
    James, MK
    Greendale, GA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) : 1549 - 1556
  • [6] Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168
  • [7] Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial
    Franke, HR
    van de Weijer, PHM
    Pennings, TMM
    van der Mooren, MJ
    [J]. FERTILITY AND STERILITY, 2000, 74 (03) : 534 - 539
  • [8] Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    De Simone, L
    Orlandi, R
    Genazzani, AR
    [J]. MATURITAS, 2001, 39 (02) : 125 - 132
  • [9] Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    Genazzani, AR
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (05) : 1180 - 1185
  • [10] ESTROGEN GESTAGEN THERAPY CHANGES SOFT-TISSUE BODY-COMPOSITION IN POSTMENOPAUSAL WOMEN
    HASSAGER, C
    CHRISTIANSEN, C
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07): : 662 - 665